Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Canales

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Medicina Clinica|July 11, 2006
[Iron deficiency anemia]Raquel de Paz, Miguel Canales, Fernando Hernández
Transfusion|December 11, 2002
Transfusion medicine illustrated. Maternofetal transfusion detected by gel-based typingBeatriz Garcia, Miguel Canales, Antonia Rodriguez, et al.
Leukemia & Lymphoma|December 14, 2011
Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphomaArmando López-Guillermo, Dolores Caballero, Miguel Canales, et al.
Leukemia Research|April 20, 2011
Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature reviewEsperanza Romero Fernández, José Ramón Paño Pardo, Andrew Doyle, et al.
British Journal of Haematology|February 6, 2016
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO groupAlejandro Martín, Alba M Redondo, Iván Dlouhy, et al.
Nuclear Medicine Communications|July 25, 2013
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatmentEva González-Barca, Miguel Canales, Montse Cortés, et al.
Archivos De Prevencion De Riesgos Laborales|April 21, 2026
Luisa María López, David García de la Cal, Jorge Martín Blanco, et al.
Leukemia Research|October 30, 2010
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphomaAna Rivero, Inmaculada Rapado, José F Tomás, et al.
Disease Markers|April 27, 2023
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell TransplantationCarmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, et al.
Eclinicalmedicine|September 4, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 studyMarek Trněný, Abraham Avigdor, Matthew S McKinney, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Medicina Clinica|July 11, 2006
[Iron deficiency anemia]Raquel de Paz, Miguel Canales, Fernando Hernández
Transfusion|December 11, 2002
Transfusion medicine illustrated. Maternofetal transfusion detected by gel-based typingBeatriz Garcia, Miguel Canales, Antonia Rodriguez, et al.
Leukemia & Lymphoma|December 14, 2011
Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphomaArmando López-Guillermo, Dolores Caballero, Miguel Canales, et al.
Leukemia Research|April 20, 2011
Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature reviewEsperanza Romero Fernández, José Ramón Paño Pardo, Andrew Doyle, et al.
British Journal of Haematology|February 6, 2016
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO groupAlejandro Martín, Alba M Redondo, Iván Dlouhy, et al.
Nuclear Medicine Communications|July 25, 2013
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatmentEva González-Barca, Miguel Canales, Montse Cortés, et al.
Archivos De Prevencion De Riesgos Laborales|April 21, 2026
Luisa María López, David García de la Cal, Jorge Martín Blanco, et al.
Leukemia Research|October 30, 2010
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphomaAna Rivero, Inmaculada Rapado, José F Tomás, et al.
Disease Markers|April 27, 2023
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell TransplantationCarmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, et al.
Eclinicalmedicine|September 4, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 studyMarek Trněný, Abraham Avigdor, Matthew S McKinney, et al.
Pageof 4